The authors concluded that influenza can be ruled in but not out by rapid influenza diagnostic tests. Sensitivity was higher in children than in adults and higher for influenza A than influenza B. Unclear sample sizes, potential for missing studies and potential for error and bias in the review process make the reliability of the findings unclear.
Study selection
Studies that compared the diagnostic accuracy of RIDTs against reference standards of viral culture or reverse transcriptase polymerase chain reaction (RT-PCR) in all age groups were eligible for inclusion. RIDT was defined as any commercially available assay that identified influenza viral antigens or neuraminidase activity in respiratory symptoms through simple immunochromatographic formats. Case-control studies and conference abstracts were excluded. Specific attempts were made to exclude studies that might have introduced incorporation and partial verification biases (details were reported in the paper).
The included studies used 26 commercially available RIDTs (Binax, Directigen and QuickVue tests were included). The reference standards were generally used with equal frequency across the studies. Just over half of the studies comprised both adults and children. Approximately one third of studies were conducted during the H1N1 2009 pandemic. Only one third of studies gave a definition of influenza-like illness. Where reported, specimens were throat, nasal or nasopharyngeal swabs, washes or aspirates.
One reviewer selected the studies for inclusion. Where there was uncertainty, a second reviewer was consulted and a consensus reached.
Assessment of study quality
Study quality was assessed with Quality Assessment of Diagnostic Accuracy Studies (QUADAS) criteria.
One reviewer carried out the quality assessment. A second reviewer checked a random sample of studies.
Data extraction
Data were extracted into 2x2 tables to enable calculation of sensitivity and specificity and computation of positive and negative likelihood ratios. Data using RT-PCR were extracted preferentially, where both reference standards were used. Tests were classed as point of care only if stated specifically. Authors were contacted for missing data, where necessary.
One reviewer extracted data. A second reviewer checked a random sample of studies.
Methods of synthesis
Sensitivity and specificity were pooled in a bivariate random-effects regression model with 95% confidence intervals (CI). A hierarchical summary receiver-operating characteristic (HSROC) curve was presented. Subgroup analyses were conducted to explore the influences of age and virus type, reference standard, RIDT commercial brand, specimen type, duration of symptoms prior to test, point of care versus laboratory testing and methodological quality. Subgroups that contained at least five studies were included in the bivariate model. Multivariate meta-regression was carried out to explore potentially interrelated variables.
